Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in Plexus Corp. (NASDAQ:PLXS - Free Report) by 66.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,832 shares of the technology company's stock after purchasing an additional 4,720 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH's holdings in Plexus were worth $1,743,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the stock. American Century Companies Inc. boosted its stake in Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company's stock worth $159,722,000 after buying an additional 338,119 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in shares of Plexus by 23.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 240,192 shares of the technology company's stock valued at $34,753,000 after acquiring an additional 45,425 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Plexus by 28.3% during the third quarter. JPMorgan Chase & Co. now owns 240,460 shares of the technology company's stock worth $34,792,000 after purchasing an additional 52,967 shares during the period. Nicola Wealth Management LTD. acquired a new position in shares of Plexus in the 3rd quarter valued at $6,655,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Plexus by 0.6% in the 3rd quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company's stock valued at $533,016,000 after purchasing an additional 22,374 shares during the last quarter. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Key Plexus News
Here are the key news stories impacting Plexus this week:
- Positive Sentiment: Q2 results and raised guidance — Plexus reported stronger-than-expected Q2 revenue (about $1.16B, roughly +18.7% Y/Y) and beat headline EPS consensus; management also issued fiscal Q3 guidance above Street estimates (EPS guidance of 2.020–2.180 and revenue guidance above prior consensus), supporting a higher-growth outlook. Earnings Press Release
- Positive Sentiment: Analyst upgrade / price-target lift — Needham raised its price target to $285 and reaffirmed a Buy, lending institutional support and providing a near-term catalyst for momentum and flows. Benzinga
- Positive Sentiment: Momentum and ETF interest — Coverage has highlighted Plexus as a momentum play and noted index/ETF buying buzz after the strong quarter, which can amplify upside through passive flows and quant strategies. Kalkine
- Neutral Sentiment: Analyst consensus / ratings landscape — The street consensus is around a “Moderate Buy” with varied price targets (median near $220); recent upgrades improve sentiment but coverage is limited, so future moves depend on continued execution. American Banking News
- Neutral Sentiment: Investor materials and call transcripts available — Management provided a slide deck and earnings call transcript that detail program wins and demand drivers; investors should review guidance detail and margin commentary for forward visibility. Earnings Presentation
- Negative Sentiment: CFO transition announced — CFO Patrick Jermain plans to retire; while Plexus says succession is disciplined, CFO turnover introduces near-term execution and disclosure risk that some investors view negatively. CFO Transition
- Negative Sentiment: Insider selling and cash-flow notes — Data shows notable insider sales in recent months and some operating cash conversion metrics were weaker y/y; these factors may temper enthusiasm and raise governance/cash-flow questions for value-focused investors. QuiverQuant
Plexus Trading Up 5.6%
NASDAQ:PLXS opened at $264.60 on Friday. The stock has a fifty day simple moving average of $211.79 and a 200 day simple moving average of $178.49. The firm has a market capitalization of $7.09 billion, a price-to-earnings ratio of 38.68 and a beta of 0.75. The company has a quick ratio of 0.75, a current ratio of 1.54 and a debt-to-equity ratio of 0.06. Plexus Corp. has a 1-year low of $115.35 and a 1-year high of $272.08.
Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, topping analysts' consensus estimates of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The firm had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same period last year, the company posted $1.66 EPS. The business's quarterly revenue was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Sell-side analysts forecast that Plexus Corp. will post 6.56 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts recently weighed in on PLXS shares. Williams Trading set a $195.00 price target on shares of Plexus in a research report on Wednesday, January 28th. Benchmark reiterated a "buy" rating and set a $220.00 target price on shares of Plexus in a research note on Monday, March 16th. Zacks Research downgraded Plexus from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 13th. Wall Street Zen raised shares of Plexus from a "hold" rating to a "buy" rating in a report on Saturday. Finally, Stifel Nicolaus set a $250.00 target price on Plexus and gave the company a "buy" rating in a research note on Monday, April 20th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Plexus presently has an average rating of "Moderate Buy" and a consensus price target of $229.17.
Check Out Our Latest Research Report on PLXS
Insider Buying and Selling at Plexus
In other Plexus news, Chairman Dean A. Foate sold 5,000 shares of the firm's stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $204.89, for a total transaction of $1,024,450.00. Following the transaction, the chairman directly owned 15,000 shares in the company, valued at $3,073,350. This trade represents a 25.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of Plexus stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $203.06, for a total transaction of $873,767.18. Following the completion of the transaction, the chief accounting officer owned 20,099 shares in the company, valued at $4,081,302.94. This trade represents a 17.63% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 50,995 shares of company stock worth $10,345,971 in the last ninety days. Company insiders own 1.78% of the company's stock.
About Plexus
(
Free Report)
Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Recommended Stories
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report